PAPER Kim JW, Kim DK, Lee HS, Park JY, Ahn HK, Ha JS, Lee D, Cho KS

Androgen Deprivation Therapy in Patients with Prostate Cancer is Associated with the Risk of Subsequent Alzheimer's Disease but not with Vascular Dementia.

World J Mens Health. 2021 Jun 29; PubMed.

PAPER Bianchi VE

Impact of Testosterone on Alzheimer's Disease.

World J Mens Health. 2022 Apr;40(2):243-256. Epub 2022 Jan 2 PubMed.

PAPER Borrione P, Tranchita E, Sansone P, Parisi A

Effects of physical activity in Parkinson's disease: A new tool for rehabilitation.

World J Methodol. 2014 Sep 26;4(3):133-43. PubMed.

PAPER Balendra R, Patani R

Quo vadis motor neuron disease?

World J Methodol. 2016 Mar 26;6(1):56-64. PubMed.

PAPER Shu S, Zhao X, Wang W, Zhang G, Cosoveanu A, Ahn Y, Wang M

Identification of a novel endophytic fungus from Huperzia serrata which produces huperzine A.

World J Microbiol Biotechnol. 2014 Dec;30(12):3101-9. Epub 2014 Sep 12 PubMed.

PAPER Go W, Ishak IH, Zarkasi KZ, Azzam G

Salvianolic acids modulate lifespan and gut microbiota composition in amyloid-β-expressing Drosophila melanogaster.

World J Microbiol Biotechnol. 2024 Oct 21;40(11):358. PubMed.

PAPER Santra A, Sinha GK, Neogi R, Thukral RK

(99m)Tc-hexamethyl propyleneamine oxime brain perfusion single photon emission computed tomography in characterization of dementia: an initial experience in Indian clinical practice.

World J Nucl Med. 2014 May;13(2):120-7. PubMed.

PAPER Shinto AS, Antony J, Kamaleshwaran K, Vijayan K, Selvan A, Korde A, Kameshwaran M, Samuel G

Correlative (99m)tc-labeled tropane derivative single photon emission computer tomography and clinical assessment in the staging of Parkinson disease.

World J Nucl Med. 2014 Sep;13(3):178-83. PubMed.

PAPER Knešaurek K

Improving (18)F-Fluoro-D-Glucose-Positron Emission Tomography/Computed Tomography Imaging in Alzheimer's Disease Studies.

World J Nucl Med. 2015 Sep-Dec;14(3):171-7. PubMed.

PAPER Huda A, Kartamihardja AH, Darmawan B, Budiawan H, Wiwie M

Metabolic Activity Value in the Posterior Cingulate Cortex Using F-18 Fluorodeoxyglucose Positron Emission Tomography Brain to Predict the Severity of Alzheimer's.

World J Nucl Med. 2017 Apr-Jun;16(2):108-113. PubMed.

PAPER Knešaurek K, Warnock G, Kostakoglu L, Burger C, for Alzheimer's Disease Neouroimaging Initiative*

Comparison of Standardized Uptake Value Ratio Calculations in Amyloid Positron Emission Tomography Brain Imaging.

World J Nucl Med. 2018 Jan-Mar;17(1):21-26. PubMed.

PAPER Lauretani F, Ruffini L, Ticinesi A, Nouvenne A, Maggio M, Meschi T

Accuracy of Quantitative Positron Emission Tomography Assessment for Differentiating Cerebral Age-related from Pathological Amyloid Deposition: A Preliminary Report from a Case-series Study.

World J Nucl Med. 2018 Apr-Jun;17(2):106-111. PubMed.

PAPER Thientunyakit T, Minoshima S

Temporal muscle uptake causing an unusual focal artifact on three-dimensional stereotactic surface projections statistical maps of (18F) fluorodeoxyglucose brain positron emission tomography in a patient with Alzheimer's disease.

World J Nucl Med. 2020 Apr-Jun;19(2):168-170. Epub 2019 Jul 23 PubMed.

PAPER Chanisa C, Monchaya N, Anchisa K, Chetsadaporn P, Attapon J

Analysis of amyloid and tau deposition in Alzheimer's disease using 11C-Pittsburgh compound B and 18F-THK 5351 positron emission tomography imaging.

World J Nucl Med. 2021 Jan-Mar;20(1):61-72. Epub 2020 Oct 8 PubMed.

PAPER Franceschi AM, Naser-Tavakolian K, Clifton M, Ahmed O, Stoffers K, Bangiyev L, Cruciata G, Clouston S, Franceschi D

Hybrid imaging in dementia: A semi-quantitative (18F)-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging approach in clinical practice.

World J Nucl Med. 2021 Jan-Mar;20(1):23-31. Epub 2020 Oct 2 PubMed.